BPC Income Statement - TTM - Birzeit Pharmaceuticals Company

Income Statement (TTM)

Birzeit Pharmaceuticals Company Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	35	36	35	40	43	45	50	48	47	47	45	45	44	43	42	40	38	41	42	46
Change (%)		2.00	-1.28	12.90	8.30	5.07	9.44	-4.40	-0.49	-0.66	-3.58	-0.66	-1.55	-2.77	-2.59	-5.95	-3.87	7.03	2.83	9.34
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	21	22	22	25	27	28	30	29	30	30	29	29	29	28	28	27	25	27	28	31
Change (%)		7.34	-1.26	12.53	7.82	4.76	7.57	-3.67	2.64	0.66	-2.79	-0.64	-0.29	-2.96	-0.62	-4.72	-5.77	9.30	3.10	8.21
% of Revenue	59.43	62.54	62.55	62.35	62.07	61.89	60.83	61.29	63.22	64.06	64.58	64.60	65.42	65.29	66.60	67.48	66.14	67.55	67.73	67.03

Gross Operating Profit	14	13	13	15	16	17	19	18	17	17	16	16	15	15	14	13	13	13	13	15
Change (%)		-5.82	-1.31	13.51	9.09	5.56	12.49	-5.53	-5.44	-2.92	-5.00	-0.69	-3.84	-2.40	-6.28	-8.41	0.06	2.58	2.27	11.72
% of Revenue	40.57	37.46	37.45	37.65	37.93	38.11	39.17	38.71	36.78	35.94	35.42	35.40	34.58	34.71	33.40	32.52	33.86	32.45	32.27	32.97

SG&A	7	7	7	7	7	7	7	8	8	7	7	7	7	8	8	7	7	6	5	5
Change (%)		0.01	1.26	2.15	1.88	1.64	4.03	3.52	1.50	-4.19	-4.11	-1.11	-1.20	13.18	-1.44	-9.78	-2.61	-17.75	-6.48	4.10
% of Revenue	18.63	18.27	18.73	16.95	15.95	15.43	14.66	15.88	16.20	15.62	15.53	15.46	15.52	18.06	18.28	17.53	17.76	13.65	12.41	11.82

R&D
Change (%)
% of Revenue

OpEx	27	29	29	32	34	35	38	37	38	37	36	36	36	36	36	34	32	33	34	36
Change (%)		5.59	-0.69	10.14	6.55	4.12	6.86	-2.28	2.40	-0.33	-3.05	-0.73	-0.47	0.13	-0.80	-5.81	-5.12	3.58	1.49	7.57
% of Revenue	78.06	80.81	81.29	79.30	78.02	77.32	75.49	77.17	79.41	79.68	80.12	80.06	80.94	83.35	84.88	85.01	83.91	81.20	80.14	78.85

Operating Income	8	7	7	8	10	10	12	11	10	10	9	9	8	7	6	6	6	8	8	10
Change (%)		-10.78	-3.75	24.89	15.00	8.41	18.25	-10.94	-10.27	-1.92	-5.68	-0.37	-5.89	-15.08	-11.54	-6.75	3.19	25.03	8.63	16.48
% of Revenue	21.94	19.19	18.71	20.70	21.98	22.68	24.51	22.83	20.59	20.32	19.88	19.94	19.06	16.65	15.12	14.99	16.09	18.80	19.86	21.15

Interest Expense	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Change (%)		31.96	-15.58	-1.41	-14.84	19.54	9.19	-7.79	6.27	-48.69	0.97	-4.60	-1.85	-10.96	-28.66	-51.55	-68.77	186.86	4.70	22.17
% of Revenue	-0.51	-0.67	-0.57	-0.50	-0.39	-0.44	-0.44	-0.43	-0.46	-0.24	-0.25	-0.24	-0.24	-0.22	-0.16	-0.08	-0.03	-0.07	-0.07	-0.08

Net Income	8	7	7	10	11	12	14	12	10	8	7	6	6	6	3	3	4	5	8	13
Change (%)		-11.01	-0.89	30.52	11.08	14.08	17.77	-18.60	-15.87	-18.41	-15.97	-8.37	-4.81	4.99	-52.76	-6.42	32.31	44.87	53.59	63.24
% of Revenue	23.56	20.55	20.63	23.85	24.46	26.56	28.58	24.34	20.57	16.90	14.73	13.58	13.13	14.18	6.88	6.84	9.42	12.75	19.04	28.43

Source: Capital IQ

Birzeit Pharmaceuticals Company - Income Statement (TTM)

Income Statement (TTM)